July 09, 2026 11:07 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Indian techie allegedly kills wife in US, sends photo of her body to 'secret girlfriend' in India; arrested | 'I fled the city': Thane doctor quits after alleged assault by Shiv Sena leader | Sensex surges 500 points before losing steam, ends marginally higher after volatile trading session | US court drops charges against Indian-origin doctor who drove Tesla off 250-foot cliff with family | Dalal Street bleeds! Sensex tanks over 1,600 points after Trump declares Iran ceasefire 'over' | 'It's over': Trump says on ceasefire with Iran | PM Modi visits 1,000-year-old Prambanan Temple in Indonesia, shares majestic aerial view of the holy site | Baruipur minor rape-murder case: Key accused Pravash Mondal killed in encounter | 'We have been cheated': Egypt coach slams refereeing after Argentina match sparks controversy | From 0-2 to victory! Argentina stage miraculous comeback amid referee drama to crush Egypt's World Cup dream

Antibiotic resistance making gonorrhoea ‘sometimes impossible’ to treat – UN health agency

| | Jul 08, 2017, at 01:49 pm
New York, July 8(Just Earth News): Gonorrhoea is becoming harder to treat due to antibiotic resistance, the United Nations health agency on Friday cautioned, adding that there is a need for better prevention and treatment of the disease that infects an estimated 78 million people each year.

“The bacteria that cause gonorrhoea are particularly smart. Every time we use a new class of antibiotics to treat the infection, the bacteria evolve to resist them,” said Dr. Teodora Wi, Medical Officer, Human Reproduction, at the UN World Health Organization (WHO).

Data from 77 countries show that “antibiotic resistance is making gonorrhoea – a common sexually-transmitted infection – much harder, and sometimes impossible, to treat,” according to the agency.

WHO noted that the current “last-resort treatment” in the form of extended-spectrum cephalosporins (ECS) has now shown resistance in more than 50 countries. As a result, the agency issued updated global treatment recommendations in 2016, advising doctors to give 2 antibiotics: ceftriaxone and azithromycin.

The development of a new antibiotic for gonorrhoea “is not attractive for commercial pharmaceutical companies,” WHO said, noting that only three candidate drugs are currently in the research-and-development pipeline.

The treatments are taken only for short periods of time, unlike medicines for chronic diseases, and they become less effective as resistance develops, meaning that the supply of new drugs constantly needs to be replenished, according to the agency.

Gonorrhoea can be prevented through safer sexual behaviour, WHO stressed. It pointed to decreasing condom use, increased urbanization and travel, poor infection detection rates, and inadequate or failed treatment for the estimated 78 million people infected each year.

“These cases may just be the tip of the iceberg, since systems to diagnose and report untreatable infections are lacking in lower-income countries where gonorrhoea is actually more common,” said Dr. Wi.

Women are particularly at risk, potentially leading to pelvic inflammatory disease, ectopic pregnancy and infertility, as well as increased risk of HIV.

Earlier this year, WHO announced that it is classifying antibiotics into three categories – Access, Watch and Reserve – to preserve the effectiveness of “last resort” antibiotics.

Photo: WHO/G. Hampton

 

Source: www.justearthnews.com

 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.